MENU
Articles by #hashtag

Pharmaceutical industry

16 hits

Richter Share Price Breaks Record

D&T
Aug 24, 2020

A three-year price record for the shares of the Hungarian pharmaceutical company Gedeon Richter was broken on Monday: the price rose above HUF 7,300 at the Budapest Stock Exchange. The company is one of the winners of the coronavirus epidemic, it is helped by the weakening of the Hungarian currency, and its sales are not […]

Sales Related Milestone at Gedeon Richter

D&T
Aug 3, 2020

For the first time in history, an original molecule invented by a CEE headquartered pharmaceutical company (Gedeon Richter's Vraylar), reached blockbuster status in the USA in the first half of 2020. "Thanks to the outstanding performance of our trusted partner Abbvie, Vraylar’s turnover exceeded USD 1 billion in Q2, which triggered the receipt of a […]

Korean Ambassador Kyoo Sik Choe and Hungarian Minister for Foreign Affiars and Trade, Péter Szijjártó (on the left) at the announcement

Samyang Biopharm: First European Unit in Gödöllő

D&T
Jul 29, 2020

South Korea-based Samyang Biopharm, specializing in medical devices, has selected Hungary for its first production unit in Europe. The HUF 8.6 billion (EUR 26.2 million) unit, will produce synthetic suture materials and create 55 new jobs in Gödöllő. The Hungarian government contributes about 15% of that amount (HUF 1.3 billion) in non-refundable support. The South […]

Reagila, developed in Hungary, Medicine of the Year

D&T
Jun 12, 2020

Richter's atypical antipsychotic, Reagila, containing the active ingredient cariprazine, was awarded the title of Drug of the Year 2019 by the Hungarian Society for Experimental and Clinical Pharmacology (HUNPHAR). Each year, the prestigious award recognizes the most advanced and effective products that have made a significant breakthrough in the cure of a disease. The award […]

Clinical Trials and the Quest for New Drugs

Viktória Villányi
May 12, 2020

The global quest for effective treatment for the quickly spreading COVID -19 pandemic demands a review and amendment of the regulations on clinical trials carried out on human subjects. To expedite market access to rapid tests, vaccines, and newly developed drugs, both the US FDA and the European Medicines Agency (EMA) have recently published recommendations […]

Rising Profits and Sales at Richter Gedeon Plc.

D&T
May 8, 2020

Sales and profit grew well above analysts' expectations in the first quarter of this year for the Hungarian pharmaceutical company Richter Gedeon Plc. The firm achieved a consolidated after tax profit of HUF 29.1 billion, which is 34.6% higher than in the same period of the previous year, and its sales revenue increased by 16.3% […]

GSK vaccine plant in Gödöllő

Vaccine Manufacturing Volume Increases in Gödöllő

D&T
Nov 14, 2019

As a result of the latest development of GlaxoSmithKline (GSK), the operations of its Hungarian factory in Gödöllő, east of Budapest have been extended to manufacture diphtheria and tetanus vaccine components for a new area of application. GlaxoSmithKline was established in 2001 by the merger of GlaxoWellcome, a company with a century-long history, and SmithKline […]

Sanofi's plant in Veresegyház

Sanofi European Competence Center to Open in Budapest

D&T
Oct 3, 2019

The leading French pharmaceutical company Sanofi is to establish a Center of Excellence in Budapest, the Hungarian Investment Promotion Agency (HIPA) announced. Initially, a hundred people will assist Sanofi subsidiaries in the field of accounting, HR and finance in seven languages, however, the center will be expanded to 350 persons by 2022. Sanofi was founded […]

Pharmaceutical research

Hungarian Pharma Firm Launches New Product

D&T
Aug 21, 2019

Hungarian pharmaceutical company Gedeon Richter Plc. said that it launched a biosimilar teriparatide drug called Terrosa® in Europe. The product is approved in adults for the same indications as Eli Lilly’s Forsteo® and is used for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture. Terrosa is also used […]

Richter's Antipsychotic Drug to Be Sold in the Middle East and North Africa

D&T
Jul 25, 2019

Hungarian pharma firm Gedeon Richter has signed an exclusive license agreement with Hikma Pharmaceuticals Plc. to sell Richter's anti-psychotic drug ‘cariprazine’ in some Middle Eastern and North African (MENA) markets. Under the terms of the agreement, Richter will be responsible for product supply and Hikma will proceed with the registration and commercialization of the product […]

The new Richter Gedeon lab in Debrecen | Zsolt Czeglédi /MTI

Pharma research lab opened in Debrecen

D&T
Mar 29, 2018

A new molecular biology laboratory of the Hungarian pharmaceutical company Richter Gedeon was inaugurated in Debrecen, E Hungary. The new lab serves the company's objectives of appearing on new markets internationally.

Xellia Pharmaceuticals testing center opens in Budapest | HIPA

Xellia Pharmaceuticals testing center opens

D&T
Aug 23, 2017

The latest development by the Danish pharmaceutical company Xellia Pharmaceuticals has been completed at its Kõbánya site in Budapest. The laboratory constructed as part of a development of EUR 11 million will operate as a testing centre for active ingredients.

Researcher in Richter's laboratory | source: richter.hu

Hungarian drug greenlighted for the EU

D&T
Jul 19, 2017

The Hungarian pharmaceutical company Gedeon Richter Plc. has announced that the European Commission has granted marketing authorization to Reagila (cariprazine) a novel antipsychotic for the treatment of schizophrenia in adult patients.

Christopher Hunley

GSK to launch new development in Hungary

D&T
Mar 16, 2017

GlaxoSmithKline (GSK) is launching a development worth EUR 57 million in its Gödöllõ plant. Upon completion of the investment, the plant will have expanded activity, producing diphtheria and tetanus vaccine (DT and TT) components for new areas of use.

Research at Richter Gedeon Plc. | source: richter.hu

A key Richter drug to be used in Western Europe

D&T
Aug 10, 2016

Hungary’s leading pharmaceutical company, Gedeon Richter Plc., has signed an exclusive license agreement with Recordati to commercialize cariprazine, a novel atypical antipsychotic in Western Europe and in Algeria, Tunisia and Turkey.

© Copyright 2020 Duax Kft. –  All rights reserved.
searchalign-justifytwitterfacebookfeedinstagrammoon-osun